Let it glow, let it glow, let it glow

0

Researchers have developed a fluorescent compound that illuminates live cancer cells.

The compound is a combination of the breast cancer drug Herceptin and a fluorescent molecule called BODIPY. Not only does it detect cancer cells under one millimetre in length, it also stops glowing when the cancer cells die, allowing doctors to evaluate the efficacy of surgery and endoscopic therapy
Unlike previous fluorescent compounds, this one should be able to be engineered to target specific types of cancer cells and may allow for better treatment of future lung cancer patients.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here